Drug Type T-lymphocyte cell therapy |
Synonyms BST008 |
Target- |
Action- |
Mechanism T lymphocyte replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseClinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-Small Cell Lung Cancer | Clinical | China | 24 Oct 2024 | |
Liver Cancer | Preclinical | China | - |